Guidance particularly addresses the value of ultrasound in patient-provider shared decision-making in management of care.

Many patients with rheumatic diseases refrain from telling their doctors about all physical and emotional symptoms they’re ...

Low patient satisfaction in psoriasis and psoriatic arthritis for clinicians and treatment is tied to need for better ...

Autoimmune diseases are those in which the body's immune system ... Sicca is not a feature of RA. Psoriatic arthritis (PSA) ...

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for ...

WASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

New data for investigational nipocalimab in Sjögren's Disease (SjD) and new research on the impact of TREMFYA ® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral ...